About the International Cancer Control Partnership (ICCP)
We are a group of organizations whose members were already individually working to support country cancer control planning.
The International Cancer Control Partnership (ICCP), formed in November 2012, is a collaboration of organizations supporting country-level cancer control planning efforts. By joining forces, these organizations align their efforts to address identified priorities, optimise their collective resources, and minimise duplication
You can explore the ICCP one-pager for an overview of the partnership and its activities, as well as the executive summary of ICCP Strategic Plan 2024-2029. Additionally, a collection of ICCP related publications, reports and blog posts authored by ICCP partners or referencing the ICCP partnership and its portal is available for consultation.
As a collaborative partnership, the ICCP aims to support all countries in addressing their response to the challenges of developing and implementing NCCPs by providing guidance throughout the entire cycle, including planning, development, implementation, and monitoring and evaluation.
The ICCP’s long-term goal is for all countries to develop and implement high-quality cancer control plans that are integrated with their broader non-communicable disease (NCD) control strategies. The ICCP emphasizes that prioritizing cancer is critical to achieving the NCD targets outlined in the Global Monitoring Framework on NCDs, the WHO Global Action Plan on NCDs and the UN Sustainable Development Goals.
The ICCP works to showcase opportunities and foster best practice partnerships across non-communicable diseases, build new synergies with existing health programs and put high level NCD commitments into actionable practice through the following:
Advocacy
Promote cancer control at global and local levels.
Bi-directional learning
Convening a bi-directional learning community of practice for cancer planners to learn from each other and from regional and global experts regarding NCCP implementation.
* Estimates from IARC's 2022 GLOBOCAN report. | ** Based on cancer plans collected on the ICCP-Portal map.
- African Organisation for Research and Training in Cancer (AORTIC)
- American Cancer Society (ACS)
- American Society of Clinical Oncology (ASCO)
- American Society for Clinical Pathology (ASCP)
- Canadian Partnership Against Cancer
- Cancer Council of the Pacific Islands
- Centers for Disease Control and Prevention USA (CDC)
- China Anti-Cancer Association (CACA)
- City Cancer Challenge Foundation (C/Can)
- ECHO Institute - University of New Mexico
- Global Focus On Cancer
- Institute of Cancer Policy
- International Atomic Energy Agency (IAEA)
- International Agency for Research on Cancer (IARC)
- International Association for Hospice & Palliative Care (IAHPC)
- International Society of Nurses in Cancer Care (ISNCC)
- Jhpiego
- Latin American and Caribbean Society of Medical Oncology (SLACOM)
- MD Anderson Cancer Center
- National Cancer Institute USA (NCI)
- National Comprehensive Cancer Network (NCCN)
- North American Association of Central Cancer Registries (NAACCR)
- Union for International Cancer Control (UICC)
- University of Hawaii
- World Health Organization - HQ
